id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S18301 R77074 |
Ban (Controls unexposed, disease free), 2012 | Termination of pregnancy | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes BZD Coexposure: No (among psychiatric (ATD and/or psychotropics) medications) |
2.20 [1.90;2.60] excluded (control group) |
654/3,392 -/- | - | 3,392 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S18302 R77077 |
Ban (Controls unexposed, sick), 2012 | Termination of pregnancy | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes BZD Coexposure: No (among psychiatric (ATD and/or psychotropics) medications) | 1.90 [1.60;2.30] | 654/3,392 -/- | - | 3,392 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S15322 R63048 |
Ornoy - BZDs, 1998 | Induced abortions | at least 1st trimester | prospective cohort | unexposed, disease free | Adjustment: No BZD Coexposure: Yes (with psychiatric (ATD and/or psychotropics) medications) | 3.50 [2.10;5.90] | 65/460 20/424 | 85 | 460 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 2 studies | 2.45 [1.36;4.43] | 85 | 3,852 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 18301